世界のベンフォチアミン市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Benfotiamine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY01965)・商品コード:GIR20MY01965
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:131
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ベンフォチアミンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ベンフォチアミンの種類別市場規模(製薬グレード、食品グレード)、用途別市場規模(栄養補助食品、糖尿病性神経障害、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Klaire、Neurohacker Collective、Kaival Chemicals、Hamari、Country Life、BioXera Pharma、Prayosha Health Care、AOR、Kimia Biosciences、XY Mogen、Ami Lifesciences、Mascot、Basil Pharmaceuticals、Pharmaffiliates、Hangzhou Eastbiopharm
・地域別グローバル市場分析 2015年-2020年
・ベンフォチアミンの北米市場(アメリカ、カナダ、メキシコ)
・ベンフォチアミンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ベンフォチアミンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ベンフォチアミンの南米市場(ブラジル、アルゼンチン)
・ベンフォチアミンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:製薬グレード、食品グレード
・用途別分析:栄養補助食品、糖尿病性神経障害、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Benfotiamine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Benfotiamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Benfotiamine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Benfotiamine market has been segmented into
Pharma Grade
Food Grade

By Application, Benfotiamine has been segmented into:
DietarySupplement
Diabetic Neuropathy
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Benfotiamine market presented in the report. This section sheds light on the sales growth of different regional and country-level Benfotiamine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Benfotiamine market.

The report offers in-depth assessment of the growth and other aspects of the Benfotiamine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Benfotiamine Market Share Analysis
Benfotiamine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Benfotiamine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Benfotiamine sales, revenue and market share for each player covered in this report.

The major players covered in Benfotiamine are:
Klaire
Neurohacker Collective
Kaival Chemicals
Hamari
Country Life
BioXera Pharma
Prayosha Health Care
AOR
Kimia Biosciences
XY Mogen
Ami Lifesciences
Mascot
Basil Pharmaceuticals
Pharmaffiliates
Hangzhou Eastbiopharm

Among other players domestic and global, Benfotiamine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Benfotiamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Benfotiamine, with price, sales, revenue and global market share of Benfotiamine in 2018 and 2019.
Chapter 3, the Benfotiamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benfotiamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Benfotiamine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Benfotiamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Benfotiamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Benfotiamine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pharma Grade
1.2.3 Food Grade
1.3 Market Analysis by Application
1.3.1 Overview: Global Benfotiamine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 DietarySupplement
1.3.3 Diabetic Neuropathy
1.3.4 Others
1.4 Overview of Global Benfotiamine Market
1.4.1 Global Benfotiamine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Klaire
2.1.1 Klaire Details
2.1.2 Klaire Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Klaire SWOT Analysis
2.1.4 Klaire Product and Services
2.1.5 Klaire Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neurohacker Collective
2.2.1 Neurohacker Collective Details
2.2.2 Neurohacker Collective Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neurohacker Collective SWOT Analysis
2.2.4 Neurohacker Collective Product and Services
2.2.5 Neurohacker Collective Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kaival Chemicals
2.3.1 Kaival Chemicals Details
2.3.2 Kaival Chemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kaival Chemicals SWOT Analysis
2.3.4 Kaival Chemicals Product and Services
2.3.5 Kaival Chemicals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hamari
2.4.1 Hamari Details
2.4.2 Hamari Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Hamari SWOT Analysis
2.4.4 Hamari Product and Services
2.4.5 Hamari Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Country Life
2.5.1 Country Life Details
2.5.2 Country Life Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Country Life SWOT Analysis
2.5.4 Country Life Product and Services
2.5.5 Country Life Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioXera Pharma
2.6.1 BioXera Pharma Details
2.6.2 BioXera Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioXera Pharma SWOT Analysis
2.6.4 BioXera Pharma Product and Services
2.6.5 BioXera Pharma Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Prayosha Health Care
2.7.1 Prayosha Health Care Details
2.7.2 Prayosha Health Care Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Prayosha Health Care SWOT Analysis
2.7.4 Prayosha Health Care Product and Services
2.7.5 Prayosha Health Care Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AOR
2.8.1 AOR Details
2.8.2 AOR Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AOR SWOT Analysis
2.8.4 AOR Product and Services
2.8.5 AOR Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Kimia Biosciences
2.9.1 Kimia Biosciences Details
2.9.2 Kimia Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Kimia Biosciences SWOT Analysis
2.9.4 Kimia Biosciences Product and Services
2.9.5 Kimia Biosciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 XY Mogen
2.10.1 XY Mogen Details
2.10.2 XY Mogen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 XY Mogen SWOT Analysis
2.10.4 XY Mogen Product and Services
2.10.5 XY Mogen Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ami Lifesciences
2.11.1 Ami Lifesciences Details
2.11.2 Ami Lifesciences Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ami Lifesciences SWOT Analysis
2.11.4 Ami Lifesciences Product and Services
2.11.5 Ami Lifesciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mascot
2.12.1 Mascot Details
2.12.2 Mascot Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mascot SWOT Analysis
2.12.4 Mascot Product and Services
2.12.5 Mascot Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Basil Pharmaceuticals
2.13.1 Basil Pharmaceuticals Details
2.13.2 Basil Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Basil Pharmaceuticals SWOT Analysis
2.13.4 Basil Pharmaceuticals Product and Services
2.13.5 Basil Pharmaceuticals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Pharmaffiliates
2.14.1 Pharmaffiliates Details
2.14.2 Pharmaffiliates Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Pharmaffiliates SWOT Analysis
2.14.4 Pharmaffiliates Product and Services
2.14.5 Pharmaffiliates Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Hangzhou Eastbiopharm
2.15.1 Hangzhou Eastbiopharm Details
2.15.2 Hangzhou Eastbiopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Hangzhou Eastbiopharm SWOT Analysis
2.15.4 Hangzhou Eastbiopharm Product and Services
2.15.5 Hangzhou Eastbiopharm Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Benfotiamine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Benfotiamine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Benfotiamine Manufacturer Market Share in 2019
3.3.2 Top 6 Benfotiamine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Benfotiamine Sales, Revenue and Market Share by Regions
4.1.1 Global Benfotiamine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Benfotiamine Revenue and Market Share by Regions (2015-2020)
4.2 North America Benfotiamine Sales and Growth Rate (2015-2020)
4.3 Europe Benfotiamine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Benfotiamine Sales and Growth Rate (2015-2020)
4.5 South America Benfotiamine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Benfotiamine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Benfotiamine Sales, Revenue and Market Share by Country
5.1.1 North America Benfotiamine Sales and Market Share by Country (2015-2020)
5.1.2 North America Benfotiamine Revenue and Market Share by Country (2015-2020)
5.2 United States Benfotiamine Sales and Growth Rate (2015-2020)
5.3 Canada Benfotiamine Sales and Growth Rate (2015-2020)
5.4 Mexico Benfotiamine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Benfotiamine Sales, Revenue and Market Share by Country
6.1.1 Europe Benfotiamine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Benfotiamine Revenue and Market Share by Country (2015-2020)
6.2 Germany Benfotiamine Sales and Growth Rate (2015-2020)
6.3 UK Benfotiamine Sales and Growth Rate (2015-2020)
6.4 France Benfotiamine Sales and Growth Rate (2015-2020)
6.5 Russia Benfotiamine Sales and Growth Rate (2015-2020)
6.6 Italy Benfotiamine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Benfotiamine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Benfotiamine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Benfotiamine Revenue and Market Share by Regions (2015-2020)
7.2 China Benfotiamine Sales and Growth Rate (2015-2020)
7.3 Japan Benfotiamine Sales and Growth Rate (2015-2020)
7.4 Korea Benfotiamine Sales and Growth Rate (2015-2020)
7.5 India Benfotiamine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Benfotiamine Sales and Growth Rate (2015-2020)
7.7 Australia Benfotiamine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Benfotiamine Sales, Revenue and Market Share by Country
8.1.1 South America Benfotiamine Sales and Market Share by Country (2015-2020)
8.1.2 South America Benfotiamine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Benfotiamine Sales and Growth Rate (2015-2020)
8.3 Argentina Benfotiamine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Benfotiamine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Benfotiamine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Benfotiamine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Benfotiamine Sales and Growth Rate (2015-2020)
9.3 Turkey Benfotiamine Sales and Growth Rate (2015-2020)
9.4 Egypt Benfotiamine Sales and Growth Rate (2015-2020)
9.5 South Africa Benfotiamine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Benfotiamine Sales and Market Share by Type (2015-2020)
10.2 Global Benfotiamine Revenue and Market Share by Type (2015-2020)
10.3 Global Benfotiamine Price by Type (2015-2020)
11 Global Benfotiamine Market Segment by Application
11.1 Global Benfotiamine Sales Market Share by Application (2015-2020)
11.2 Global Benfotiamine Revenue Market Share by Application (2015-2020)
11.3 Global Benfotiamine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Benfotiamine Sales, Revenue and Growth Rate (2021-2025)
12.2 Benfotiamine Market Forecast by Regions (2021-2025)
12.2.1 North America Benfotiamine Market Forecast (2021-2025)
12.2.2 Europe Benfotiamine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Benfotiamine Market Forecast (2021-2025)
12.2.4 South America Benfotiamine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Benfotiamine Market Forecast (2021-2025)
12.3 Benfotiamine Market Forecast by Type (2021-2025)
12.3.1 Global Benfotiamine Sales Forecast by Type (2021-2025)
12.3.2 Global Benfotiamine Market Share Forecast by Type (2021-2025)
12.4 Benfotiamine Market Forecast by Application (2021-2025)
12.4.1 Global Benfotiamine Sales Forecast by Application (2021-2025)
12.4.2 Global Benfotiamine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Benfotiamine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Benfotiamine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Benfotiamine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Klaire Basic Information, Manufacturing Base and Competitors
Table 8. Klaire Benfotiamine Major Business
Table 9. Klaire Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 10. Klaire SWOT Analysis
Table 11. Klaire Benfotiamine Product and Services
Table 12. Klaire Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Neurohacker Collective Basic Information, Manufacturing Base and Competitors
Table 14. Neurohacker Collective Benfotiamine Major Business
Table 15. Neurohacker Collective Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 16. Neurohacker Collective SWOT Analysis
Table 17. Neurohacker Collective Benfotiamine Product and Services
Table 18. Neurohacker Collective Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Kaival Chemicals Basic Information, Manufacturing Base and Competitors
Table 20. Kaival Chemicals Benfotiamine Major Business
Table 21. Kaival Chemicals Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 22. Kaival Chemicals SWOT Analysis
Table 23. Kaival Chemicals Benfotiamine Product and Services
Table 24. Kaival Chemicals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Hamari Basic Information, Manufacturing Base and Competitors
Table 26. Hamari Benfotiamine Major Business
Table 27. Hamari Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 28. Hamari SWOT Analysis
Table 29. Hamari Benfotiamine Product and Services
Table 30. Hamari Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Country Life Basic Information, Manufacturing Base and Competitors
Table 32. Country Life Benfotiamine Major Business
Table 33. Country Life Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 34. Country Life SWOT Analysis
Table 35. Country Life Benfotiamine Product and Services
Table 36. Country Life Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BioXera Pharma Basic Information, Manufacturing Base and Competitors
Table 38. BioXera Pharma Benfotiamine Major Business
Table 39. BioXera Pharma Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 40. BioXera Pharma SWOT Analysis
Table 41. BioXera Pharma Benfotiamine Product and Services
Table 42. BioXera Pharma Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Prayosha Health Care Basic Information, Manufacturing Base and Competitors
Table 44. Prayosha Health Care Benfotiamine Major Business
Table 45. Prayosha Health Care Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 46. Prayosha Health Care SWOT Analysis
Table 47. Prayosha Health Care Benfotiamine Product and Services
Table 48. Prayosha Health Care Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AOR Basic Information, Manufacturing Base and Competitors
Table 50. AOR Benfotiamine Major Business
Table 51. AOR Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 52. AOR SWOT Analysis
Table 53. AOR Benfotiamine Product and Services
Table 54. AOR Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Kimia Biosciences Basic Information, Manufacturing Base and Competitors
Table 56. Kimia Biosciences Benfotiamine Major Business
Table 57. Kimia Biosciences Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 58. Kimia Biosciences SWOT Analysis
Table 59. Kimia Biosciences Benfotiamine Product and Services
Table 60. Kimia Biosciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. XY Mogen Basic Information, Manufacturing Base and Competitors
Table 62. XY Mogen Benfotiamine Major Business
Table 63. XY Mogen Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 64. XY Mogen SWOT Analysis
Table 65. XY Mogen Benfotiamine Product and Services
Table 66. XY Mogen Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Ami Lifesciences Basic Information, Manufacturing Base and Competitors
Table 68. Ami Lifesciences Benfotiamine Major Business
Table 69. Ami Lifesciences Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 70. Ami Lifesciences SWOT Analysis
Table 71. Ami Lifesciences Benfotiamine Product and Services
Table 72. Ami Lifesciences Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Mascot Basic Information, Manufacturing Base and Competitors
Table 74. Mascot Benfotiamine Major Business
Table 75. Mascot Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 76. Mascot SWOT Analysis
Table 77. Mascot Benfotiamine Product and Services
Table 78. Mascot Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Basil Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Basil Pharmaceuticals Benfotiamine Major Business
Table 81. Basil Pharmaceuticals Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 82. Basil Pharmaceuticals SWOT Analysis
Table 83. Basil Pharmaceuticals Benfotiamine Product and Services
Table 84. Basil Pharmaceuticals Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Pharmaffiliates Basic Information, Manufacturing Base and Competitors
Table 86. Pharmaffiliates Benfotiamine Major Business
Table 87. Pharmaffiliates Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 88. Pharmaffiliates SWOT Analysis
Table 89. Pharmaffiliates Benfotiamine Product and Services
Table 90. Pharmaffiliates Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Hangzhou Eastbiopharm Basic Information, Manufacturing Base and Competitors
Table 92. Hangzhou Eastbiopharm Benfotiamine Major Business
Table 93. Hangzhou Eastbiopharm Benfotiamine Total Revenue (USD Million) (2017-2018)
Table 94. Hangzhou Eastbiopharm SWOT Analysis
Table 95. Hangzhou Eastbiopharm Benfotiamine Product and Services
Table 96. Hangzhou Eastbiopharm Benfotiamine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Benfotiamine Sales by Manufacturer (2018-2019) (MT)
Table 98. Global Benfotiamine Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Benfotiamine Sales by Regions (2015-2020) (MT)
Table 100. Global Benfotiamine Sales Market Share by Regions (2015-2020)
Table 101. Global Benfotiamine Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Benfotiamine Sales by Countries (2015-2020) (MT)
Table 103. North America Benfotiamine Sales Market Share by Countries (2015-2020)
Table 104. North America Benfotiamine Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Benfotiamine Revenue Market Share by Countries (2015-2020)
Table 106. Europe Benfotiamine Sales by Countries (2015-2020) (MT)
Table 107. Europe Benfotiamine Sales Market Share by Countries (2015-2020)
Table 108. Europe Benfotiamine Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Benfotiamine Sales by Regions (2015-2020) (MT)
Table 110. Asia-Pacific Benfotiamine Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Benfotiamine Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Benfotiamine Sales by Countries (2015-2020) (MT)
Table 113. South America Benfotiamine Sales Market Share by Countries (2015-2020)
Table 114. South America Benfotiamine Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Benfotiamine Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Benfotiamine Sales by Countries (2015-2020) (MT)
Table 117. Middle East & Africa Benfotiamine Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Benfotiamine Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Benfotiamine Revenue Market Share by Countries (2015-2020)
Table 120. Global Benfotiamine Sales by Type (2015-2020) (MT)
Table 121. Global Benfotiamine Sales Share by Type (2015-2020)
Table 122. Global Benfotiamine Revenue by Type (2015-2020) (USD Million)
Table 123. Global Benfotiamine Revenue Share by Type (2015-2020)
Table 124. Global Benfotiamine Sales by Application (2015-2020) (MT)
Table 125. Global Benfotiamine Sales Share by Application (2015-2020)
Table 126. Global Benfotiamine Sales Forecast by Regions (2021-2025) (MT)
Table 127. Global Benfotiamine Market Share Forecast by Regions (2021-2025)
Table 128. Global Benfotiamine Sales Forecast by Type (2021-2025) (MT)
Table 129. Global Benfotiamine Market Share Forecast by Type (2021-2025)
Table 130. Global Benfotiamine Sales Forecast by Application (2021-2025)
Table 131. Global Benfotiamine Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Benfotiamine Picture
Figure 2. Global Sales Market Share of Benfotiamine by Type in 2019
Figure 3. Pharma Grade Picture
Figure 4. Food Grade Picture
Figure 5. Benfotiamine Sales Market Share by Application in 2018
Figure 6. DietarySupplement Picture
Figure 7. Diabetic Neuropathy Picture
Figure 8. Others Picture
Figure 9. Global Benfotiamine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Benfotiamine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Benfotiamine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Benfotiamine Sales Market Share by Manufacturer in 2019
Figure 30. Global Benfotiamine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Benfotiamine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Benfotiamine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Benfotiamine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Benfotiamine Revenue Market Share by Regions in 2018
Figure 38. North America Benfotiamine Sales and Growth Rate (2015-2020)
Figure 39. Europe Benfotiamine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Benfotiamine Sales and Growth Rate (2015-2020)
Figure 41. South America Benfotiamine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Benfotiamine Sales and Growth Rate (2015-2020)
Figure 43. North America Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Benfotiamine Sales Market Share by Countries (2015-2020)
Figure 45. North America Benfotiamine Sales Market Share by Countries in 2018
Figure 46. North America Benfotiamine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Benfotiamine Revenue Market Share by Countries in 2018
Figure 48. United States Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Benfotiamine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Benfotiamine Revenue Market Share by Countries in 2019
Figure 54. Germany Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Benfotiamine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Benfotiamine Revenue Market Share by Regions 2019
Figure 62. China Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Benfotiamine Sales Market Share by Countries in 2019
Figure 69. South America Benfotiamine Revenue Market Share by Countries in 2019
Figure 70. Brazil Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Benfotiamine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Benfotiamine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Benfotiamine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Benfotiamine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Benfotiamine Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Benfotiamine Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Benfotiamine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Benfotiamine Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Benfotiamine Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Benfotiamine Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Benfotiamine Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Benfotiamine Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Klaire、Neurohacker Collective、Kaival Chemicals、Hamari、Country Life、BioXera Pharma、Prayosha Health Care、AOR、Kimia Biosciences、XY Mogen、Ami Lifesciences、Mascot、Basil Pharmaceuticals、Pharmaffiliates、Hangzhou Eastbiopharm

★調査レポート[世界のベンフォチアミン市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20MY01965)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のベンフォチアミン市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆